These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30845359)

  • 1. A multiple methods approach to determine adherence with prescribed mycophenolate in children with kidney transplant.
    Almardini R; Taybeh EO; Alsous MM; Hawwa AF; McKeever K; Horne R; McElnay JC
    Br J Clin Pharmacol; 2019 Jul; 85(7):1434-1442. PubMed ID: 30845359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to antiepileptic medicines in children: a multiple-methods assessment involving dried blood spot sampling.
    Shah NM; Hawwa AF; Millership JS; Collier PS; Ho P; Tan ML; Peake D; Tirupathi S; Bothwell J; Bailie N; Shepherd C; Craig J; McElnay JC
    Epilepsia; 2013 Jun; 54(6):1020-7. PubMed ID: 23448146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of mycophenolic acid during the early period after renal transplant.
    Nazemian F; Mohammadpur AH; Abtahi B; Naghibi M
    Exp Clin Transplant; 2007 Dec; 5(2):658-63. PubMed ID: 18194117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of mycophenolate mofetil.
    Bullingham RE; Nicholls AJ; Kamm BR
    Clin Pharmacokinet; 1998 Jun; 34(6):429-55. PubMed ID: 9646007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of mycophenolic acid in renal transplant recipients.
    van Hest RM; van Gelder T; Vulto AG; Mathot RA
    Clin Pharmacokinet; 2005; 44(10):1083-96. PubMed ID: 16176120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetic Analysis of Immediate-Release Oral Tacrolimus Co-administered with Mycophenolate Mofetil in Corticosteroid-Free Adult Kidney Transplant Recipients.
    Rong Y; Mayo P; Ensom MHH; Kiang TKL
    Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):409-422. PubMed ID: 30377942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft.
    Neumann I; Fuhrmann H; Kanzler M; Fang IF; Jaeger A; Graf H; Bayer P; Kovarik J
    Expert Opin Pharmacother; 2008 Apr; 9(6):879-86. PubMed ID: 18377332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualization of mycophenolate mofetil dose in renal transplant recipients.
    van Hest RM; Hesselink DA; Vulto AG; Mathot RA; van Gelder T
    Expert Opin Pharmacother; 2006 Mar; 7(4):361-76. PubMed ID: 16503809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.
    Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
    Clin Chem; 2001 Jan; 47(1):88-94. PubMed ID: 11148182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience.
    Santos SM; Carlos CM; Cabanayan-Casasola CB; Danguilan RA
    Transplant Proc; 2012 Jan; 44(1):154-60. PubMed ID: 22310603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to cardiovascular pharmacotherapy by patients in Iraq: A mixed methods assessment using quantitative dried blood spot analysis and the 8-item Morisky Medication Adherence Scale.
    Alalaqi A; Lawson G; Obaid Y; Tanna S
    PLoS One; 2021; 16(5):e0251115. PubMed ID: 33989336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation.
    Mourad M; Malaise J; Chaib Eddour D; De Meyer M; König J; Schepers R; Squifflet JP; Wallemacq P
    Clin Chem; 2001; 47(7):1241-8. PubMed ID: 11427455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Trial of a Multicomponent Intervention to Promote Medication Adherence: The Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT).
    Foster BJ; Pai ALH; Zelikovsky N; Amaral S; Bell L; Dharnidharka VR; Hebert D; Holly C; Knauper B; Matsell D; Phan V; Rogers R; Smith JM; Zhao H; Furth SL
    Am J Kidney Dis; 2018 Jul; 72(1):30-41. PubMed ID: 29602631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of mycophenolate sodium and comparison with the mofetil formulation in stable kidney transplant recipients.
    Cattaneo D; Cortinovis M; Baldelli S; Bitto A; Gotti E; Remuzzi G; Perico N
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1147-55. PubMed ID: 17928466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant mycophenolate mofetil pharmacokinetics in Mexican children.
    Villa M; González R; García-Roca P; Hernández AM; Ortiz L; Castañeda-Hernández G; Medeiros M
    Proc West Pharmacol Soc; 2011; 54():66-8. PubMed ID: 22423584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients.
    Zhao W; Fakhoury M; Deschênes G; Roussey G; Brochard K; Niaudet P; Tsimaratos M; André JL; Cloarec S; Cochat P; Bensman A; Azougagh S; Jacqz-Aigrain E
    J Clin Pharmacol; 2010 Nov; 50(11):1280-91. PubMed ID: 20147615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil: a unique immunosuppressive agent.
    Hood KA; Zarembski DG
    Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device.
    Zwart TC; Gokoel SRM; van der Boog PJM; de Fijter JW; Kweekel DM; Swen JJ; Guchelaar HJ; Moes DJAR
    Br J Clin Pharmacol; 2018 Dec; 84(12):2889-2902. PubMed ID: 30176064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
    Staatz CE; Tett SE
    Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.